These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23652551)
1. Phosphate toxicity and vascular mineralization. Razzaque MS Contrib Nephrol; 2013; 180():74-85. PubMed ID: 23652551 [TBL] [Abstract][Full Text] [Related]
2. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Voelkl J; Lang F; Eckardt KU; Amann K; Kuro-O M; Pasch A; Pieske B; Alesutan I Cell Mol Life Sci; 2019 Jun; 76(11):2077-2091. PubMed ID: 30887097 [TBL] [Abstract][Full Text] [Related]
3. Klotho deficiency causes vascular calcification in chronic kidney disease. Hu MC; Shi M; Zhang J; Quiñones H; Griffith C; Kuro-o M; Moe OW J Am Soc Nephrol; 2011 Jan; 22(1):124-36. PubMed ID: 21115613 [TBL] [Abstract][Full Text] [Related]
4. Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease. Ogata H; Sugawara H; Yamamoto M; Ito H J Atheroscler Thromb; 2024 Jan; 31(1):1-14. PubMed ID: 37766573 [TBL] [Abstract][Full Text] [Related]
5. Mineralization/anti-mineralization networks in the skin and vascular connective tissues. Li Q; Uitto J Am J Pathol; 2013 Jul; 183(1):10-8. PubMed ID: 23665350 [TBL] [Abstract][Full Text] [Related]
6. Recent progress in the treatment of vascular calcification. O'Neill WC; Lomashvili KA Kidney Int; 2010 Dec; 78(12):1232-9. PubMed ID: 20861819 [TBL] [Abstract][Full Text] [Related]
7. Klotho: an elixir of youth for the vasculature? Shroff R; Shanahan CM J Am Soc Nephrol; 2011 Jan; 22(1):5-7. PubMed ID: 21164022 [No Abstract] [Full Text] [Related]
8. Hyperphosphatemia and zinc deficiency in chronic kidney disease: unpacking their interconnected roles and nutritional implications. Williams CR Am J Physiol Renal Physiol; 2024 May; 326(5):F857-F859. PubMed ID: 38511220 [No Abstract] [Full Text] [Related]
9. Breast cancer, alcohol, and phosphate toxicity. Brown RB; Bigelow P; Dubin JA; Neiterman E J Appl Toxicol; 2024 Jan; 44(1):17-27. PubMed ID: 37332052 [TBL] [Abstract][Full Text] [Related]
10. Impacts of Oral Florfenicol Medication and Residues on the Kidney and Liver of Nile Tilapia Oreochromis niloticus (L.). Bardhan A; Abraham TJ; Singha J; Rajisha R; Krishna EKN; Panda SK; Patil PK Vet Sci; 2023 Jan; 10(1):. PubMed ID: 36669037 [TBL] [Abstract][Full Text] [Related]
11. Phosphate Dysregulation and Neurocognitive Sequelae. Acquaviva J; Abdelhady HG; Razzaque MS Adv Exp Med Biol; 2022; 1362():151-160. PubMed ID: 35288879 [TBL] [Abstract][Full Text] [Related]
12. Phosphate and Cellular Senescence. Hu MC; Moe OW Adv Exp Med Biol; 2022; 1362():55-72. PubMed ID: 35288873 [TBL] [Abstract][Full Text] [Related]
13. Extracellular Phosphate, Inflammation and Cytotoxicity. Michigami T; Yamazaki M; Razzaque MS Adv Exp Med Biol; 2022; 1362():15-25. PubMed ID: 35288869 [TBL] [Abstract][Full Text] [Related]
14. Should We Consider the Cardiovascular System While Evaluating CKD-MBD? Rroji M; Figurek A; Spasovski G Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32106499 [TBL] [Abstract][Full Text] [Related]
15. Dietary phosphate toxicity: an emerging global health concern. Erem S; Razzaque MS Histochem Cell Biol; 2018 Dec; 150(6):711-719. PubMed ID: 30159784 [TBL] [Abstract][Full Text] [Related]
16. Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial. Zittermann A; Ernst JB; Prokop S; Fuchs U; Dreier J; Kuhn J; Knabbe C; Börgermann J; Berthold HK; Pilz S; Gouni-Berthold I; Gummert JF Int J Endocrinol; 2018; 2018():5015417. PubMed ID: 30057603 [TBL] [Abstract][Full Text] [Related]
17. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients. Mizuiri S; Nishizawa Y; Yamashita K; Mizuno K; Ishine M; Doi S; Masaki T; Shigemoto K Nephrology (Carlton); 2018 Sep; 23(9):837-845. PubMed ID: 28703899 [TBL] [Abstract][Full Text] [Related]
18. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423 [TBL] [Abstract][Full Text] [Related]